WHV Investments’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$4.27M Buy
157,454
+148,170
+1,596% +$3.97M 2.29% 19
2015
Q4
$270K Buy
9,284
+34
+0.4% +$941 0.01% 97
2015
Q3
$254K Hold
9,250
0.01% 123
2015
Q2
$254K Hold
9,250
0.01% 117
2015
Q1
$247K Buy
+9,250
New +$213K ﹤0.01% 117
2014
Q4
Sell
-9,250
Closed -$220K 148
2014
Q3
$220K Hold
9,250
﹤0.01% 149
2014
Q2
$214K Sell
9,250
-142
-2% -$3.13K ﹤0.01% 151
2014
Q1
$214K Sell
9,392
-17,458
-65% -$372K ﹤0.01% 148
2013
Q4
$496K Sell
26,850
-44,250
-62% -$771K 0.01% 180
2013
Q3
$1.2M Buy
71,100
+1,600
+2% +$26.9K 0.01% 185
2013
Q2
$1.08M Buy
+69,500
New +$1.16M 0.01% 189

Other funds holding NVO

WHV Investments's NVO Position: Q1 2016 in Review

WHV Investments increased its Novo Nordisk (NVO) stake by 1,596% in Q1 2016, buying an estimated $3.97M and bringing the position to 157,454 shares worth $4.27M. The position accounts for 2.29% of the portfolio, ranked #19.

WHV Investments first reported a position in NVO in Q2 2013 and has held it in 11 quarters since. 536 funds tracked by Wall St. Rank hold NVO as of Q1 2016.

  • WHV Investments held 157,454 shares of Novo Nordisk worth $4.27M as of Q1 2016.
  • WHV Investments bought 148,170 Novo Nordisk shares in Q1 2016, an estimated $3.97M.
  • Novo Nordisk made up 2.29% of WHV Investments's portfolio in Q1 2016, its #19 holding.
  • WHV Investments first reported a position in Novo Nordisk in Q2 2013 and has held it in 11 quarters since.
  • 536 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2016.

Based on WHV Investments's 13F filing for Q1 2016, filed 11 May 2016.